Search Results - "Therapeutic approach"

Pathogenic mechanisms and therapeutic approaches for the tauopathies

Table of Contents: “…Contents: Tauopathies -- Alzheimer's Disease and frontal temporal lobe dementia -- Pathogenic mechanisms -- Therapeutic approaches for the tauopathies.…”
Get full text
Series (Alzheimer's disease)
Series (Drug discovery and development in the neurosciences)

Pathogenic mechanisms and therapeutic approaches for the tauopathies

Table of Contents: “…Contents: Tauopathies -- Alzheimer's Disease and frontal temporal lobe dementia -- Pathogenic mechanisms -- Therapeutic approaches for the tauopathies.…”
Get full text
Series (Alzheimer's disease)
Series (Drug discovery and development in the neurosciences)

Pathogenic mechanisms and therapeutic approaches for the tauopathies

Table of Contents: “…Contents: Tauopathies -- Alzheimer's Disease and frontal temporal lobe dementia -- Pathogenic mechanisms -- Therapeutic approaches for the tauopathies.…”
Get full text
Series (Alzheimer's disease)
Series (Drug discovery and development in the neurosciences)

Stroke rehabilitation part 2, therapies and treatments /

Table of Contents: “…Contents: Technologies -- Cognitive rehab -- Integration of new therapeutic approaches -- Shifting care to community -- Early-supported discharge.…”
Get full text
Series

Stroke rehabilitation part 2, therapies and treatments /

Table of Contents: “…Contents: Technologies -- Cognitive rehab -- Integration of new therapeutic approaches -- Shifting care to community -- Early-supported discharge.…”
Get full text
Series

SOD1-related ALS what has it told us about motor neuron degeneration? Part 2 of 2/

Table of Contents: “…Contents: Mechanisms of motor neuron injury in the presence of SOD1 mutations -- glutamate-mediated excitotoxicity -- Determinants of fast and slow disease progression -- Therapeutic approaches including gene therapy.…”
Get full text
Series

SOD1-related ALS what has it told us about motor neuron degeneration? Part 2 of 2/

Table of Contents: “…Contents: Mechanisms of motor neuron injury in the presence of SOD1 mutations -- glutamate-mediated excitotoxicity -- Determinants of fast and slow disease progression -- Therapeutic approaches including gene therapy.…”
Get full text
Series

Astrocytes and Alexander disease the first, but not last, primary astrocyte disease /

Table of Contents: “…Contents: GFAP in astrocytes: isolation, genetics and function -- Alexander disease: clinical and pathologic features -- Mouse models for studying pathogenesis -- Potential therapeutic approaches: reduction of GFAP and manipulation of stress response.…”
Get full text
Series

Astrocytes and Alexander disease the first - but not last - primary astrocyte disease /

Table of Contents: “…Contents: GFAP in astrocytes: isolation, genetics and function -- Alexander disease: clinical and pathologic features -- Mouse models for studying pathogenesis -- Potential therapeutic approaches: reduction of GFAP and manipulation of stress response.…”
Get full text
Series

Astrocytes and Alexander disease the first - but not last - primary astrocyte disease /

Table of Contents: “…Contents: GFAP in astrocytes: isolation, genetics and function -- Alexander disease: clinical and pathologic features -- Mouse models for studying pathogenesis -- Potential therapeutic approaches: reduction of GFAP and manipulation of stress response.…”
Get full text
Series

Sjogren's syndrome current knowledge and future prospects /

Table of Contents: “…Contents: Introduction to Sjögren's syndrome -- Humoral and cellular autoimmune responses in Sjögren's syndrome -- Description of heterogenic clinical features of disease -- Pathogenetic/immunopathologic aspects and associations with clinical phenotypes -- The need for precise therapeutic approaches -- Development and features of lymphoma in Sjögren's syndrome -- Risk factors for development of severe disease -- Biomarkers for disease severity, outcome and lymphoma.…”
Get full text
Series

Sjogren's syndrome current knowledge and future prospects /

Table of Contents: “…Contents: Introduction to Sjögren's syndrome -- Humoral and cellular autoimmune responses in Sjögren's syndrome -- Description of heterogenic clinical features of disease -- Pathogenetic/immunopathologic aspects and associations with clinical phenotypes -- The need for precise therapeutic approaches -- Development and features of lymphoma in Sjögren's syndrome -- Risk factors for development of severe disease -- Biomarkers for disease severity, outcome and lymphoma.…”
Get full text
Series

Sjogren's syndrome current knowledge and future prospects /

Table of Contents: “…Contents: Introduction to Sjögren's syndrome -- Humoral and cellular autoimmune responses in Sjögren's syndrome -- Description of heterogenic clinical features of disease -- Pathogenetic/immunopathologic aspects and associations with clinical phenotypes -- The need for precise therapeutic approaches -- Development and features of lymphoma in Sjögren's syndrome -- Risk factors for development of severe disease -- Biomarkers for disease severity, outcome and lymphoma.…”
Get full text
Series

Palin parent-child interaction therapy

Table of Contents: “…Contents: Multifactorial model of onset & development of stuttering -- Therapeutic approach: core values -- Risk factors for young children who stutter -- Screening for vulnerability to persistence and appropriate care pathways -- Assessment of stuttering -- Principles of Palin Parent-Child Interaction (PCI) Therapy -- Using video analysis in PCI therapy -- Three main strands of PCI therapy: interaction, family, child (strategies).…”
Get full text
Series

Palin parent-child interaction therapy

Table of Contents: “…Contents: Multifactorial model of onset & development of stuttering -- Therapeutic approach: core values -- Risk factors for young children who stutter -- Screening for vulnerability to persistence and appropriate care pathways -- Assessment of stuttering -- Principles of Palin Parent-Child Interaction (PCI) Therapy -- Using video analysis in PCI therapy -- Three main strands of PCI therapy: interaction, family, child (strategies).…”
Get full text
Series

Palin parent-child interaction therapy

Table of Contents: “…Contents: Multifactorial model of onset & development of stuttering -- Therapeutic approach: core values -- Risk factors for young children who stutter -- Screening for vulnerability to persistence and appropriate care pathways -- Assessment of stuttering -- Principles of Palin Parent-Child Interaction (PCI) Therapy -- Using video analysis in PCI therapy -- Three main strands of PCI therapy: interaction, family, child (strategies).…”
Get full text
Series

The neurological symptoms of COVID-19

Table of Contents: “…Contents: Diversity and incidence of neurological symptoms attributable to COVID-19 -- Mechanisms by which SARS-CoV-2 infection triggers neurological symptoms -- Singularity of SARS-CoV-2, among coronaviruses, in triggering neurological symptoms -- Therapeutic approaches to prevent or improve neurological symptoms -- Incidence of psychiatric symptoms resulting from COVID-19 in a subset of patients -- Relationship between neurological and psychiatric symptoms.…”
Get full text
Series

The neurological symptoms of COVID-19

Table of Contents: “…Contents: Diversity and incidence of neurological symptoms attributable to COVID-19 -- Mechanisms by which SARS-CoV-2 infection triggers neurological symptoms -- Singularity of SARS-CoV-2, among coronaviruses, in triggering neurological symptoms -- Therapeutic approaches to prevent or improve neurological symptoms -- Incidence of psychiatric symptoms resulting from COVID-19 in a subset of patients -- Relationship between neurological and psychiatric symptoms.…”
Get full text
Series

Lysosomal storage diseases

Table of Contents: “…Contents: Lysosomes are multifunctional -- Lysosome related organelles -- Complexity & functions of lysosomal proteins -- Lysosomal storage diseases -- Sphingolipid lysosomal storage diseases as an example -- Lysosomal diseases: multimorbidity disorders -- Pathogenic cascade beyond the Lysosomal System -- Specific therapies approved for some diseases -- Molecular mechanisms and therapeutic approaches of LSDs -- Lysosomal enzymes -- ERTs: approved or in advanced clinical trials -- Approved small molecules: SRT & EET -- Multiple gene therapy trials: enzyme deficiencies -- Cellular organelles targeted by LSD therapies -- Lysosomal & neurodegenerative diseases.…”
Get full text
Series

Lysosomal storage diseases

Table of Contents: “…Contents: Lysosomes are multifunctional -- Lysosome related organelles -- Complexity & functions of lysosomal proteins -- Lysosomal storage diseases -- Sphingolipid lysosomal storage diseases as an example -- Lysosomal diseases: multimorbidity disorders -- Pathogenic cascade beyond the Lysosomal System -- Specific therapies approved for some diseases -- Molecular mechanisms and therapeutic approaches of LSDs -- Lysosomal enzymes -- ERTs: approved or in advanced clinical trials -- Approved small molecules: SRT & EET -- Multiple gene therapy trials: enzyme deficiencies -- Cellular organelles targeted by LSD therapies -- Lysosomal & neurodegenerative diseases.…”
Get full text
Series